JMSB News Alert John Marshall Bk Fal (JMSB) 17.7500 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
John Marshall Bk Fal (JMSB) 17.7500 $JMSB

John Marshall Bank Reports Continued Growth and Profitability
Business Wire - Fri Feb 06, 8:10AM CST
John Marshall Bank (OTCQB: JMSB) (the "Bank" reported net income of $8.0 million for the year ended December 31, 2014, an increase of $930 thousand, or 13.1%, as compared to net income of $7.1 million reported for the year ended December 31, 2013. Net income per diluted share declined 17.9% during 2014 to $0.92 per share, compared to $1.12 per share during 2013. The decline in net income per diluted share is primarily attributed to the dilutive effect of the Bank's November 2013 common stock offering of 2.4 million shares at $13.50 per share. As of December 31, 2014, the Bank's tangible book value per share was $12.00, up 9.7% compared to $10.94 as of December 31, 2013.

John Marshall Bank Reports Quarterly Financial Results
Business Wire - Fri Oct 31, 2:40PM CDT
John Marshall Bank (OTCQB: JMSB) (the "Bank" reported net income of $5.8 million for the nine months ended September 30, 2014, an increase of $642 thousand, or 12.4%, as compared to net income of $5.2 million reported for the nine months ended September 30, 2013. Net income per diluted share declined 23.0% to $0.67 per share during the first nine months of 2014, compared to $0.87 per share during the same period in 2013. The decline in net income per diluted share is primarily attributed to the dilutive effect of the Bank's November 2013 common stock offering of 2.4 million shares at $13.50 per share. As of September 30, 2014, the Bank's tangible book value per share was $11.73, up 19.3% compared to $9.83 as of September 30, 2013.

John Marshall Bank Reports Mid-Year Financial Results
Business Wire - Wed Jul 30, 12:55PM CDT
John Marshall Bank (OTCQB: JMSB) (the "Bank" reported net income of $3.8 million for the six months ended June 30, 2014, an increase of $425 thousand, or 12.7%, as compared to net income of $3.4 million reported for the six months ended June 30, 2013. Net income per diluted share declined 23.2% to $0.43 per share during the first six months of 2014, compared $0.56 per share during the same period in 2013. The decline in net income per diluted share is primarily attributed to the dilutive effect of the Bank's November 2013 common stock offering of 2.4 million shares at $13.50 per share. As of June 30, 2014, the Bank's tangible book value per share was $11.47, up 20.8% compared to $9.50 as of June 30, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading